Stem Cell-Based Therapy for Lung Disease

This book presents state-of-the-art pre-clinical models and clinical applications of stem-cell-based therapies applied to different lung diseases, with a special focus on the translation of bench data into clinical studies. Starting with the assumption that abnormal lung tissue repair and regenerati...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Burgess, Janette K. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Heijink, Irene H. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
Έκδοση:1st ed. 2019.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • 1 Chronic lung pathologies that require repair and regeneration
  • I Stem/stromal cells populations in the lung
  • 2 Characterization of stromal/stem cells in the lung and translation of knowledge of stem/stromal cell population to human lung
  • 3 Comparison of the regenerative potential for lung tissue of mesenchymal stromal cells from different sources/locations within the body
  • 4 The potential of factors released from mesenchymal stromal cells as therapeutic agents in the lung
  • II Preclinical evidence and clinical applications in Chronic Lung Diseases
  • 5 Preclinical evidence for the role of stem/stromal cells in COPD
  • 6 Clinical application of stem/stromal cells in COPD
  • 7 Evidence for the role of stem/stromal cells in lung fibrosis
  • 8 Preclinical evidence for the role of stem/stromal cells and their therapeutic potential in treating BPD and PAH
  • 9 Crispr-Cas9 editing in induced pluripotent stem cells: a way forward for treating Cystic Fibrosis?
  • 10 Clinical application of stem/stromal cells in cystic fibrosis
  • 11 Preclinical evidence for the role of stem/stromal cells in targeting ARDS
  • 12 The safety and efficiency of addressing ARDS using stem cell therapies in clinical trials
  • III Stem cell delivery systems and devices
  • 13 Spraying as route of delivery for stem cells to the lungs
  • IV Conclusion
  • 14 Conclusion.